Hartford Hospital's Institute of Living is the first medical facility in the state to offer the NeuroStar TMS Therapy system.
NeuroStar TMS is the first and only TMS Therapy® device cleared by the FDA for the treatment of patients who failed to benefit from prior antidepressant treatment. (TMS stands for “transcranial magnetic stimulation.”)
NeuroStar TMS Therapy is a non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of neuromodulation. It stimulates nerve cells in an area of the brain that is linked to depression by delivering highly focused MRI-strength magnetic pulses.
Patients being treated by NeuroStar TMS Therapy do not require anesthesia or sedation and remain awake and alert. It is a 40-minute outpatient procedure that is prescribed by a psychiatrist and performed in a psychiatrist’s office. The treatment is typically administered daily for 4-6 weeks.
Current TMS Research Studies
Learn More About TMS: